ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMS Ims Health Holdings, Inc.

31.34
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ims Health Holdings, Inc. NYSE:IMS NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 31.34 0 01:00:00

IDC MarketScape Names IMS Health a Global Leader in Life Sciences Sales and Marketing Outsourcing

27/10/2015 12:00pm

Business Wire


IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more IMS HEALTH HOLDINGS, INC. Charts.

Industry Gives High Marks for IMS Health’s Technical Skills, Global Capabilities and Expert Insights

IMS Health (NYSE:IMS) has been named a global leader in IDC Health Insights’ annual assessment of sales and marketing business process outsourcing (BPO) services available to the life sciences industry. The report, IDC MarketScape: Worldwide Life Science Sales and Marketing BPO 2015 Vendor Assessment (doc #HI258820, September 2015), cites IMS Health’s extensive industry expertise relative to other vendors and gives the company high marks for its technical skills.

“Outsourcing within the life science industry continues to expand as what is considered ‘core’ to business slowly shrinks and more of everyday operations become fair game for externalization,” said Eric Newmark, program director of IDC Health Insights’ Life Science Business Systems Strategy service. "Life science companies are interested in vendors with proven attributes, including deep industry-specific expertise with a strong book of reference; a willingness to provide dedicated resources on an ongoing basis and across sequential projects to maintain acquired best practices; and a proven understanding of industry regulations and compliance initiatives.”

The IDC MarketScape assessment is based on detailed surveys and vendor interviews, publicly available information and end-user experiences. For purposes of the report, BPO includes outsourcing of all services such as call center, customer support, data analysis, report generation, marketing and sales operations, predictive modeling and research services, sales training, content creation, opportunity assessment, competitive intelligence, knowledge management services, social media analytics and forecasting as a service.

“We’re very pleased with this acknowledgment of our services strength by IDC and our clients,” said José Luis Fernández, senior vice president, Global Services, IMS Health. “Life sciences companies are looking for partners that can pull together the right market and technology capabilities, information assets and expert resources. We’re uniquely positioned to help them solve complex challenges and run their operations more effectively.”

An excerpt of the IDC MarketScape: Worldwide Life Science Sales and Marketing BPO 2015 Vendor Assessment can be viewed at www.imshealth.com/idcbpo2015. More information about IMS Health’s global services can be found at www.imshealth.com.

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.

About IDC MarketScape

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

IMS HealthTor Constantino, +1.484.567.6732tconstantino@us.imshealth.com

1 Year IMS HEALTH HOLDINGS, INC. Chart

1 Year IMS HEALTH HOLDINGS, INC. Chart

1 Month IMS HEALTH HOLDINGS, INC. Chart

1 Month IMS HEALTH HOLDINGS, INC. Chart

Your Recent History

Delayed Upgrade Clock